A combined gene signature model for predicting radiotherapy response and relapse-free survival in laryngeal squamous cell carcinoma.

Cancer Cell Int · 2025 · PMC11916850 · PMID 40102978

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

p53 and p16 showed a trend of downregulation in the non-CR group (Supplementary Table 1C).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.